(S (NP (NP (NNP Hepatitis) (NNP C) (NN virus)) (PRN (-LRB- -LRB-) (NP (NNP HCV)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB widely) (JJ spread)) (NN disease)) (PP (ADVP (DT all)) (IN over) (NP (DT the) (NN world))))) (. .))
(S (NP (NNP HCV)) (VP (VBZ has) (NP (NP (ADJP (RB very) (JJ high)) (NN mutation) (NN rate)) (SBAR (WHNP (WDT that)) (S (VP (VBZ makes) (S (NP (PRP it)) (ADJP (JJ resistant) (PP (TO to) (NP (NNS antibodies)))))))))) (. .))
(S (S (VP (VBG Modeling) (NP (NNP HCV)) (S (VP (TO to) (VP (VB identify) (NP (DT the) (NN virus) (NN mutation) (NN process))))))) (VP (VBZ is) (ADJP (JJ essential) (PP (TO to) (NP (NP (PRP$ its) (NN detection)) (CC and) (S (VP (VBG predicting) (NP (PRP$ its) (NN evolution)))))))) (. .))
(S (NP (DT This) (NN paper)) (VP (VBZ presents) (NP (NP (DT a) (ADJP (NN model) (VBN based)) (NN framework)) (PP (IN for) (S (VP (VBG estimating) (NP (NP (NN mutation) (NN rate)) (PP (IN of) (NP (NNP HCV)))) (PP (IN in) (NP (CD two) (NNS steps)))))))) (. .))
(S (ADVP (RB Firstly)) (NP (JJ profile) (JJ hidden) (NNP Markov) (NN model) (PRN (-LRB- -LRB-) (NP (NNP PHMM)) (-RRB- -RRB-)) (NN architecture)) (VP (VBD was) (NP (VBN builder)) (S (VP (TO to) (VP (VB select) (NP (NP (DT the) (NNS sequences)) (SBAR (WHNP (WDT which)) (S (VP (VBZ represents) (NP (NP (NN sequence)) (PP (IN per) (NP (NN year)))))))))))) (. .))
(S (ADVP (RB Secondly)) (NP (NN mutation) (NN rate)) (VP (VBD was) (VP (VBN calculated) (PP (IN by) (S (VP (VBG using) (NP (NP (JJ pair-wise) (NN distance) (NN method)) (PP (IN between) (NP (NNS sequences))))))))) (. .))
(S (NP (NP (DT A) (NN pilot) (NN study))) (VP (VBZ is) (VP (VBN conducted) (PP (IN on) (NP (NP (NNP NS5B) (NN zone)) (PP (IN of) (NP (NP (NNP HCV) (NN dataset)) (PP (IN of) (NP (NP (NN genotype) (CD 4) (NN subtype) (DT a)) (PRN (-LRB- -LRB-) (NP (NNP HCV4a)) (-RRB- -RRB-)))) (PP (IN in) (NP (NNP Egypt))))))))) (. .))
